Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [POLITICS]

2 clusters · 4 sources · 5 days · First seen 5 days ago · Last updated about 5 hours ago

Nicole Saphier Surgeon General nomination

Overview

Nicole Saphier, the nominee for U.S. Surgeon General, released financial disclosures ahead of her Senate confirmation hearing. The filings revealed a diverse investment portfolio spanning the tobacco, pharmaceutical, technology, energy, and fast food industries. Saphier has pledged to divest from these holdings if confirmed.

During her hearing before the Committee on Health, Education, Labor, and Pensions, lawmakers are expected to examine her public health views, particularly her skepticism regarding certain vaccine recommendations. The nomination follows previous unsuccessful attempts to fill the position, including the stalled candidacy of Dr. Casey Means and the withdrawal of Janette Nesheiwat. Saphier’s background in the wellness industry and her alignment with the administration’s health policies, including those of Health Secretary Robert F. Kennedy Jr., remain key points of scrutiny.

Entities

Nicole Saphier · Donald Trump · Philip Morris International · Memorial Sloan Kettering Cancer Center · Robert F. Kennedy Jr.

Timeline

about 5 hours ago

[POLITICS] 2 sources
Nicole Saphier faces Senate hearing for surgeon general nomination
Dr. Nicole Saphier, Donald Trump’s third nominee for U.S. surgeon general, faces a Senate confirmation hearing regarding her medical background and views on public health and vaccination.
5 days ago

[POLITICS] 2 sources
Nicole Saphier discloses diverse stock holdings ahead of Surgeon General hearing
Surgeon General nominee Nicole Saphier disclosed financial holdings in tobacco, big pharma, tech, and fast food companies, pledging to divest from these assets if confirmed.

Sources

gizmodo.com · joemygod.com · justthenews.com · srnnews.com